• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A novel Transformation Model© for personalized medicine laboratory systems.

作者信息

McKibben Linda J, Boone D Joe, Marchibroda Janet, Issa Amalia M

机构信息

US FDA, MD, USA.

Battelle Inc., Columbus, OH, USA.

出版信息

Per Med. 2010 Jan;7(1):87-94. doi: 10.2217/pme.09.66.

DOI:10.2217/pme.09.66
PMID:29783368
Abstract

The role of health system laboratories is critical to the appropriate clinical integration of personalized medicine. We conducted semistructured interviews with experts and opinion leaders representing laboratory medicine, health policy and the diagnostics industry, to examine what is known about the real-world effectiveness of health laboratories as organizations. We describe and encourage the wider use of an evidence-based, novel Transformation Model© to prepare for the future and set goals for a better health system. A collaborative approach appropriately integrates the efficiency and high-quality expertise of the health laboratory system with the transformative vision of the personalized medicine community.

摘要

相似文献

1
A novel Transformation Model© for personalized medicine laboratory systems.
Per Med. 2010 Jan;7(1):87-94. doi: 10.2217/pme.09.66.
2
Personalized medicine policy challenges: measuring clinical utility at point of care.个性化医学政策面临的挑战:在护理点衡量临床效用。
Expert Rev Pharmacoecon Outcomes Res. 2012 Jun;12(3):289-95. doi: 10.1586/erp.12.15.
3
How molecular medicine transforms policy (and everything else).分子医学如何改变政策(以及其他一切)。
J Biolaw Bus. 2004;7(3):16-9.
4
Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe.检验科是否已准备好迎接个体化医学时代?一项针对欧洲医院/医学院校检验科主任的调查。
Clin Chem Lab Med. 2015 Jun;53(7):981-8. doi: 10.1515/cclm-2015-0171.
5
Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in Europe.检验医学是否已为个性化医疗时代做好准备?一项针对欧洲医院/医学院校检验医学主任的调查。
Drug Metab Pers Ther. 2015 Jun;30(2):121-8. doi: 10.1515/dmdi-2015-0012.
6
Assessing patient readiness for the clinical adoption of personalized medicine.评估患者对临床采用个性化医疗的准备情况。
Public Health Genomics. 2009;12(3):163-9. doi: 10.1159/000189629. Epub 2009 Feb 10.
7
The current status and future potential of personalized diagnostics: Streamlining a customized process.个性化诊断的现状与未来潜力:简化定制流程
Biotechnol Annu Rev. 2008;14:411-22. doi: 10.1016/S1387-2656(08)00015-X.
8
The intersection of biotechnology and pharmacogenomics: health policy implications.
Health Aff (Millwood). 2006 Sep-Oct;25(5):1271-80. doi: 10.1377/hlthaff.25.5.1271.
9
The revitalization of U.S. dental education.美国牙科教育的振兴。
J Dent Educ. 2008 Feb;72(2 Suppl):28-42.
10
Innovative tests for patient-tailored treatments: demonstrating value in the age of personalized medicine.针对患者定制治疗的创新测试:在个性化医疗时代彰显价值。
Per Med. 2011 Mar;8(2):183-189. doi: 10.2217/pme.10.90.

引用本文的文献

1
Evaluating genomic tests from bench to bedside: a practical framework.从实验室到临床评估基因组检测:一个实用框架。
BMC Med Inform Decis Mak. 2012 Oct 19;12:117. doi: 10.1186/1472-6947-12-117.